TaiGen Biotechnology News
Most Popular TaiGen Biotechnology Story
Taiwan's TaiGen raises $37M
In a move that the company says will "greatly expedite [its] growth," Taiwan's TaiGen Biotechnology--a company that develops infectious diseases, cancer and diabetes drugs--has garnered $37 million Read more...
Latest Headlines
- January 21, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
